Target intelligence / Profile preview

Cell membranes and channel fenestrations

Molecular classification
Ion channel structural feature, Voltage-gated ion channel
01

Overview

Cell membranes and channel fenestrations refer to the lipid environment and the lateral openings within the transmembrane architecture of voltage-gated ion channels, such as sodium (Nav) and calcium (Cav) channels (Payandeh et al., 2011, Nature). These fenestrations provide a 'hydrophobic pathway' that allows lipid-soluble drug molecules to migrate from the surrounding cell membrane directly into the central cavity of the ion channel pore (Hille, 1977, Journal of General Physiology). This mechanism is distinct from the 'aqueous pathway' where drugs enter through the open intracellular gate, allowing drugs to access their binding sites even when the channel is in a closed or inactivated state. Understanding these structures is crucial for the design of state-dependent blockers used in treating cardiac arrhythmias, epilepsy, and chronic pain, as they determine the kinetics and affinity of drug binding (Gamal El-Din et al., 2018, PNAS). The dimensions and chemical environment of these fenestrations are key determinants of drug potency and selectivity, making them a major focus in pharmacology for modulating electrical signaling in excitable tissues (Catterall & Swanson, 2015, Neuron).

Other names
Lateral fenestrationsHydrophobic access pathwayLipid-exposed poresSide portalsIntramembrane fenestrations
02

Mechanism of action

Facilitates the entry of hydrophobic or amphiphilic drug molecules from the lipid bilayer into the central pore of ion channels, bypassing the aqueous gate.

03

Biological functions

Ion transport regulationDrug permeationLipid-protein interactionMembrane signaling
04

Disease associations

Cardiac arrhythmiaChronic painEpilepsyHypertension
05

Safety considerations

Non-specific lipid interactionsState-dependent toxicityDifficulty in targeting specific channel isoforms due to conserved fenestration structuresLipid-solubility related drug accumulation
06

Interacting drugs

Lidocaine

6 more in the full profile.

Beyond the preview

Go deeper on Cell membranes and channel fenestrations.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membranes and channel fenestrations.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call